Pure Global

Myoglobin - India CDSCO Medical Device Registration

Myoglobin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000171_59cbb1f4a0ed5814a467b6ef6a91ca8f_9a4f11ed62a810e79f5ebd8b60c9ed5f. This device is marketed under the brand name CLIA. The license holder is Star Biomed Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Myoglobin
UID: IMP/IVD/2023/000171_59cbb1f4a0ed5814a467b6ef6a91ca8f_9a4f11ed62a810e79f5ebd8b60c9ed5f

Brand Name

CLIA

License Holder

Star Biomed Pvt. Ltd.

Device Class

Class B

Approving Authority

CDSCO

Product Information

Myoglobin (CLIA) is a chemiluminescence immunoassay test for the quantitative measurement of circulating Myoglobin (CLIA) in human serum, anticoagulated whole blood and plasma, which is intended as an aid to diagnosis of myocardial infarction. The assay can be used for samples over the range of 1ng/mL~1000ng/mL

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing